600713 南京醫藥
按盤價 
6.400 +0.430 (+7.203%) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 8.912 | 8.598 | 9.293 | 11.232 | 11.399 |
| 總資產報酬率 ROA (%) | 2.012 | 1.932 | 1.924 | 2.071 | 2.050 |
| 投入資產回報率 ROIC (%) | 3.587 | 3.341 | 3.788 | 4.160 | 3.721 | 邊際利潤分析 |
| 銷售毛利率 (%) | 6.154 | 6.282 | 6.183 | 6.490 | 6.509 |
| 營業利潤率 (%) | 2.111 | 1.906 | 1.880 | 1.860 | 1.874 |
| 息稅前利潤/營業總收入 (%) | 2.946 | 2.829 | 2.823 | 2.671 | 2.838 |
| 淨利潤/營業總收入 (%) | 1.515 | 1.384 | 1.330 | 1.426 | 1.353 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 89.973 | 104.125 | 96.540 | 114.275 | 104.192 |
| 價值變動淨收益/利潤總額(%) | 0.439 | 0.400 | 0.877 | -5.369 | -10.459 |
| 營業外收支淨額/利潤總額(%) | -0.214 | -1.994 | -3.003 | -3.125 | -0.816 | 償債能力分析 |
| 流動比率 (X) | 1.534 | 1.627 | 1.401 | 1.313 | 1.339 |
| 速動比率 (X) | 1.161 | 1.259 | 1.089 | 1.053 | 1.081 |
| 資產負債率 (%) | 73.742 | 74.610 | 74.464 | 78.848 | 79.781 |
| 帶息債務/全部投入資本 (%) | 52.957 | 60.549 | 55.948 | 56.498 | 63.038 |
| 股東權益/帶息債務 (%) | 82.934 | 61.108 | 73.364 | 71.618 | 52.905 |
| 股東權益/負債合計 (%) | 31.000 | 29.879 | 30.419 | 24.042 | 22.304 |
| 利息保障倍數 (X) | 3.507 | 2.946 | 2.829 | 3.082 | 2.899 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 81.405 | 79.619 | 87.571 | 90.106 | 79.332 |
| 存貨周轉天數 (天) | 46.028 | 43.223 | 41.478 | 39.498 | 36.623 |
| 備註： | 即時報價更新時間為 15/04/2026 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
